# Major Recall Alert: DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC Recalled Due to Incorrect Product Monograph
If you're a healthcare professional or patient utilizing DRAXIMAGE products, take note of this recent recall. The Canadian government has issued a recall for **DRAXIMAGE SODIUM IODIDE I131 SOLUTION**, USP DIAGNOSTIC due to a critical packaging concern: **the affected lots may contain an incorrect product monograph.** This error could lead to incorrect usage directions, posing potential safety risks. Learn more below to ensure your safety and compliance.
## Why This Recall is Important
Recalls involving medical-grade diagnostic solutions are always treated with urgency, as patient safety is at stake. **DRAXIMAGE SODIUM IODIDE I131 SOLUTION** is a diagnostic product widely used in nuclear medicine, often for the treatment or diagnosis of thyroid-related conditions. Having accurate information regarding dosage and usage is vital for healthcare professionals administering the product, as any discrepancy or confusion stemming from the packaging could compromise patient outcomes or cause severe medical errors.
Incorrect product monographs can:
- Provide wrong or misleading instructions for use.
- Lead to improper dosages, potentially harming patients.
- Delay essential treatments due to confusion or uncertainty.
This recall highlights the importance of vigilance in providing accurate medical product packaging to avoid any adverse effects.
## Details of the Recall
Here are some crucial facts about this recall:
- **Product Name**: DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC
- **Brand**: DRAXIMAGE
- **Issue**: Packaging of the affected lots includes an incorrect product monograph.
- **Type of Recall**: Voluntary Recall for Safety Concerns
- **Date Announced**: 29718
- **Official Source**: [Health Canada Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/draximage-sodium-iodide-i131-solution-usp-diagnostic-may-contain-incorrect-product)
For additional context, the **product monograph** in question is a critical document that includes information on dosage, indications, administration, and potential risks associated with this diagnostic solution. Any misinformation here poses significant safety challenges for healthcare providers and patients alike.
## What You Should Do
If you or your healthcare organization uses **DRAXIMAGE SODIUM IODIDE I131 SOLUTION**, it’s essential to take action immediately.
- **Verify Product Packaging**: Cross-check the product monograph included in the package with accurate details from the official source link provided above.
- **Stop Use**: If you identify an affected lot, cease using the product immediately until further guidance is provided by the manufacturer or Health Canada.
- **Contact DRAXIMAGE**: Reach out to the manufacturer or the distributor for further clarification or to arrange the return of the product.
- **Report Issues**: Healthcare providers encountering adverse reactions or errors should report their experiences to Health Canada’s MedEffect program.
Being proactive in addressing this recall will help ensure optimal safety for all patients and mitigate potential health risks.
## Stay Safe – Get Instant Recall Alerts
In today’s fast-paced health environment, staying informed about recalls is crucial. Don’t miss critical notices that could impact your health or practice!
**Download the MyRecalls app now** to receive real-time recall alerts and updates directly to your phone. Stay ahead of potential risks and protect yourself with fast, accurate recall information.
For more details about this recall, visit the official Health Canada notice [here](https://recalls-rappels.canada.ca/en/alert-recall/draximage-sodium-iodide-i131-solution-usp-diagnostic-may-contain-incorrect-product).
Ensuring that diagnostic solutions like **DRAXIMAGE SODIUM IODIDE I131 SOLUTION** are used correctly is crucial in providing safe, effective patient care. By staying informed and vigilant, we can all contribute to a safer healthcare ecosystem.
**Don’t wait until it's too late — stay updated and stay safe!**